Ferring Pharmaceuticals SA Representative Office in Romania Ferring is a company with a tremendous history dating back to the 1950s in Sweden. Now present in over 50 countries, the Group has managed to maintain a double digit annual growth over the last 2 decades. Focusing on Romania in particular, can you first of all tell us more…
Bayer Healthcare Pharmaceuticals Russia You were a Russian manager from 1996-2004, departed to Germany for some time, and recently made your way back to Russia in 2010. How has Russian healthcare and industry changed, and what do you find most striking? The biggest difference is the fact that the government is much more involved…
Watson Pharmaceuticals Watson is one the largest generic players in the US but the international presence of the company is still relatively modest. Watson does not have commercial operations in India but you acquired Sekhsaria Chemicals back in 2006, as well as a formulations plant in Goa from Dr Reddy’s. Could you…
Contract Manufacturing The managing director of Encube Ethicals discusses contract manufacturing in India today, growing competition from China, and partnering with the world’s leading multinational pharma companies. Mr Dilip Shah from the Indian Pharmaceutical Alliance told us that the main strength of India is manufacturing, so of course, contract manufacturing as…
Ferring Pharmaceuticals UK Shire’s International Marketing to being COO of start-up medical device company, Medicsight. What about Ferring and your current role attracted you to take this job and what are you bringing on board that is unique from your past experiences? As you mentioned, I have quite an extensive career and would…
Lupin Pharmaceuticals Inc. Two weeks ago, Lupin announced its annual results, portraying 6 years of sustained growth and a net profit up by 27%. How pleased were you with this performance, and were you expecting such strong results? We were pleased, but not very pleased. We thought that we could have done much…
MSD pharmaceuticals Pvt. Ltd. While your appointment as Managing Director was not a long time ago, you immediately faced the big task to oversee one of the most complicated corporate mergers the local Indian drug industry has seen in recent years. How challenging was the integration of Fulford and Organon for you? One of…
GlaxoSmithKline Pharmaceuticals Limited - Ind A catalyst of India’s shifting industry dynamics has been the sector’s M&A activity. We already saw majors such as Piramal going to Abbott and Ranbaxy to Daiichi-Sankyo… And while Andrew Witty has publicly announced to pursue acquisitions here, growth has largely been organically. Is it too late for GSK to…
Calyx Chemicals and Pharmaceuticals Limited You founded Calyx in 1979 with a three-person team. At the time, you were just 21 years old! What was the vision behind the creation of the company? Essentially, the vision was to become a specialized API player, which could cater to both the Indian market and the international market.…
Glenmark Glenmark may be poised to release India’s first novel drug, from the in-licensed, anti-diarrheal molecule Crofelemer. Crofelemer has successfully complete Phase III trials, and you are readying to release it across 140 countries. What stage of the process are you in? When will we see India’s first novel drug in…
Ferring Pharmaceuticals Poland As we are just entering 2011, could you share with us the results of the Polish affiliate in 2010? 2010 was for Ferring Poland a year of reconstruction. The affiliate has been rebuilding the business with significant internal changes that are supposed to reflect changes in the external environment. The…
NatureWise Biotech & Medicals Corp. Where is NatureWise most focused today as a company? NatureWise is mainly focused on histone deacetylase (HDAC) inhibitors, especially in the new area of anti-cancer target therapy. These HDAC inhibitor compounds have multiple uses, so they are also good for dementia, Alzheimer’s and other rare neurodegenerative diseases. Over the past…
See our Cookie Privacy Policy Here
